The vaccine against coronavirus disease may be likely in early 2021.
Five vaccine projects, two in the US and three in China, are in phase 1 clinical trials.
73 vaccine candidates are in exploratory or pre-clinical stages.
Scientists are leveraging existing work on vaccines against Mers, which is another coronavirus.
Fast-tracked regulatory approvals, rapid response platforms and parallel development phases are being used.
